Publications

Project

Impact of preventive pill-based treatment on migraine days: A secondary outcome study of the Childhood and Adolescent Migraine Prevention (CHAMP) trial and a comparison of self-report to nosology-derived assessments

Robert C Gibler, James L Peugh, Christopher S Coffey, Leigh Ann Chamberlin, Dixie Ecklund, Elizabeth Klingner, Jon Yankey, Leslie L Korbee, Marielle Kabbouche, Joanne Kacperski, Linda L Porter, Brooke L Reidy, Andrew D Hershey, Scott W Powers

Headache. 2023 February 9;

PubMed:

https://pubmed.ncbi.nlm.nih.gov/36757131/

Multi-Site Observational Study to Assess Biomarkers for Susceptibility or Resilience to Chronic Pain: The Acute to Chronic Pain Signatures (A2CPS) Study Protocol

Giovanni Berardi, Laura Frey-Law, Kathleen A Sluka, Emine O Bayman, Christopher S Coffey, Dixie Ecklund, Carol G T Vance, Dana L Dailey, John Burns, Asokumar Buvanendran, Robert J McCarthy, Joshua Jacobs, Xiaohong Joe Zhou, Richard Wixson, Tessa Balach, Chad M Brummett, Daniel Clauw, Douglas Colquhoun, Steven E Harte, Richard E Harris, David A Williams, Andrew C Chang, Jennifer Waljee, Kathleen M Fisch, Kristen Jepsen, Louise C Laurent, Michael Olivier, Carl D Langefeld, Timothy D Howard, Oliver Fiehn, Jon M Jacobs, Panshak Dakup, Wei-Jun Qian, Adam C Swensen, Anna Lokshin, Martin Lindquist, Brian S Caffo, Ciprian Crainiceanu, Scott Zeger, Ari Kahn, Tor Wager, Margaret Taub, James Ford, Stephani P Sutherland, Laura D Wandner

Front Med (Lausanne). 2022 April 25; 9 (10.3389/fmed.2022.849214)

PubMed:

PMC9082267

Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial

Griguer CE, Oliva CR, Coffey CS, Cudkowicz ME, Conwit RA, Gudjonsdottir AL, Ecklund DJ, Fedler JK, Neill-Hudson TM, Nabors LB, Benge M, Hackney JR, Chase M, Leonard TP, Patel T, Colman H, de la Fuente M, Chaudhary R, Marder K, Kreisl T, Mohile N, Chheda MG, McNeill K, Kumthekar P, Dogan A, Drappatz J, Puduvalli V, Kowalska A, Graber J, Gerstner E, Clark S, Salacz M, Markert J.

Neurooncology Advances. 2021 December 24; 4 (1) doi: 10.1093/noajnl/vdab1.

PubMed:

PMID:35088051

Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study

Nowak RJ, Coffey CS, Goldstein JM, Dimachkie MM, Benatar M, Kissel JT, Wolfe GI, Burns TM, Freimer ML, Nations S, Granit V, Smith AG, Richman DP, Ciafaloni E, Al-Lozi MT, Sams LA, Quan D, Ubogu E, Pearson B, Sharma A, Yankey JW, Uribe L, Shy M, Amato AA, Conwit R, O'Connor KC, Hafler DA, Cudkowicz ME, Barohn RJ; NeuroNEXT NN103 BeatMG Study Team.

Neurology. 2021 December 2; (DOI: https://doi.org/10.1)

PubMed:

PMID: 34857535

Virtual coordinator and site training and reorganization of a multisite consortium upon grant renewal: Challenges of the NeuroNEXT network

Lowenhaupt, Stephanie. Molloy, Angela.

Contemporary Clinical Trials Communications. 2021 July 26; 23 (DOI: 10.1016/j.conctc.202)

PubMed:

PMID: 34381918

Safety and Efficacy of N-Acetylmannosamine (ManNAc) in Patients with GNE Myopathy: An Open-Label Phase 2 Study

Carillo N, Malicdan MC, Leoyklang P, Shrader JA, Joe G, Slota C, Perreault J, Heiss JD, Class B, Liu CY, Bradley K, Jodarski C, Ciccone C, Driscoll C, Parks R, Van Wart S, Bayman L, Coffey CS, Quintana M, Berry SM, Huizing M, and Gahl WA

Genetics in Medicine. 2021 July 13; 23 (11) 2067-2075.

PubMed:

PMID: 34257421

Prevalence of Headache Days and Disability 3 Years After Participation in the Childhood and Adolescent Migraine Prevention Medication Tria

Scott W. Powers, PhD; Christopher S. Coffey, PhD; Leigh A. Chamberlin, RD, MEd; Dixie J. Ecklund, RN, MSN; Elizabeth A. Klingner, MS; Jon W. Yankey, MS; James L. Peugh, PhD; Leslie L. Korbee, BS; Kerry Simmons, BS; Stephanie M. Sullivan, BS; Marielle A. Kabbouche, MD; Joanne Kacperski, MD; Linda L. Porter, PhD; Brooke L. Reidy, PhD; Andrew D. Hershey, MD, PhD

JAMA Network Open. 2021 July 12; 4 (7)

PubMed:

34251445